Clinical Trials

1,157 enrolled 1 FDA

BreastGynecologicHead & Neck

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

NCT05768139 2026-05-22

PIKALO-1

Phase 1/2 Recruiting

880 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT05006196 2026-05-20

IMOGEN

Active not recruiting

1,030 enrolled

Breast Diseases, Breast Neoplasms

NCT07581834 2026-05-12

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Phase 2 Recruiting

2,000 enrolled

BreastGynecologicHead & Neck

Breast Diseases, Breast Neoplasms

NCT06993844 2026-05-06

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

233 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT04964934 2026-04-21

SERENA-6

315 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT05386108 2026-04-06

ELECTRA

Phase 1/2 Recruiting

73 enrolled

BreastCNS

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT07505797 2026-04-01

AUDIBLE

800 enrolled

Breast Diseases, Breast Neoplasms, Cystic Fibrosis, Fibroadenoma, Mastodynia

NCT07500428 2026-03-30

BUST-AI Bench

1,380 enrolled

Breast Diseases, Breast Neoplasms

NCT03709446 2026-03-19

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Phase 1/2 Completed

17 enrolled

Phase 1 Active not recruiting

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07038369 2026-03-17

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

134 enrolled

BreastGenitourinaryGynecologic

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05720039 2026-02-24

SP NSM

Phase NA Active not recruiting

204 enrolled

Breast Diseases, Breast Neoplasms

NCT06780176 2026-02-06

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

800 enrolled

Breast Diseases, Breast Neoplasms

NCT04854304 2026-01-15

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Active not recruiting

500 enrolled

Breast Diseases

NCT07313514 2026-01-02

MMO

100 enrolled

Breast Diseases

NCT04711252 2025-10-14

SERENA-4

1,370 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT06335069 2025-09-24

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Phase 2 Recruiting

20 enrolled

Breast Diseases, Breast Neoplasms

NCT07010939 2025-09-12

PERSEVERE

3,000 enrolled

Breast Diseases, Breast Neoplasms

NCT06886659 2025-07-22

A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)

Phase 1 Completed

80 enrolled

Phase 1/2 Active not recruiting

Breast Diseases, Breast Neoplasms

NCT03304080 2025-07-18

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

44 enrolled

Breast Diseases, Breast Neoplasms

NCT06187350 2025-06-06

AIM-RÖ

Completed

60,000 enrolled

Breast Diseases, Breast Neoplasms, Neoplasms

NCT04774471 2025-06-03

Advanced Diffusion Tensor MRI for Breast Cancer

Completed

68 enrolled

Breast Diseases, Breast Neoplasms

NCT04711109 2025-04-02

BRCA-P

300 enrolled

Breast Diseases, Breast Neoplasms, Neoplasms

NCT01299987 2025-03-30

TARGIT-E

Phase NA Completed

591 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT06805812 2025-02-03

PALMARES-2

3,500 enrolled

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT04151368 2025-01-31

RNSM

Phase NA Suspended

30 enrolled

Breast Diseases, Breast Neoplasms, Genetic Predisposition to Disease

NCT06765395 2025-01-09

Explore Association Models Between Environmental Hormones andBreast Cancer

Active not recruiting

687 enrolled

Breast Diseases, Breast Neoplasms

NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting

200 enrolled

Breast Diseases, Breast Neoplasms, Neoplasms

NCT04177108 2024-03-27

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase 3 Completed

242 enrolled 12 charts

Phase NA Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases, Triple Negative Breast Neoplasms

NCT05441943 2024-03-05

Lymphaticovenous Anastomosis as Treatment for Lymphedema

10 enrolled